Skip to main content

Deze website is uitsluitend voorbehouden aan beroepsbeoefenaren in Nederland.

header-banner crswnp

Loss of the sense of smell is a major symptom of chronic rhinosinusitis with nasal polyps, affecting up to 90% of patients.1,2 Smell loss, which results in considerable lifestyle and psychological disease burden3, is a key indicator of type 2 inflammation4 and may be the first sign of the disease recurrence.1,2

Type 2 Inflammation and Loss of Smell

  • Loss of the sense of smell is one of the major symptoms of CRSwNP1,2
  • It impacts patients QoL3, and may persist even after the surgery4
  • Type 2 inflammation may play a role in yielding anosmia/hyposmia5
  • It affects ≈90% of CRSwNP patients1
  • Anosmia/hyposmia can be an early indicator of disease recurrence1,2
  • Degree of type 2 inflammation is correlated with severity of impairment of smell1,2

Smell loss is associated with type 2 inflammation5–9

smell-loss type2

Smell loss represents a major burden for CRSwNP patients1,2

QoL icon

Reduced quality of life (HR-QoL)1,10

DAILY ACTIVITIES

Daily activities are affected3

DEPRESSION PHOBIA

Depression, anxiety, phobia, irritation, fatigue etc.3

RELATIONSHIPS icon

Altered interpersonal relationships11

ECONOMIC BURDEN

Economic burden, decreased productivity12

Smell improvement as measure of disease control

1 - International Guidelines


Emphasize the importance of the loss of the ability to smell as a treatment target13-14

2 - Assessment of olfaction


Is crucial for clinical evaluation of CRS1

3 - Management of smell loss


Is complex and requires a multifaceted approach19-21

1/3

1 - International Guidelines


Emphasize the importance of the loss of the ability to smell as a treatment target13-14

2 - Assessment of olfaction


Is crucial for clinical evaluation of CRS1

3 - Management of smell loss


Is complex and requires a multifaceted approach19-21

Neem contact op

Get in touch - dupixent
Wij staan klaar

Heeft u vragen of wilt u meer weten? Wij zorgen dat u zo snel mogelijk geholpen wordt.

MAT-BE-2600575 (v1.0) 04/05/2026